Company Search:
Advanced Search
Sponsored Links
Agios Pharmaceuticals Inc Company Snapshot
Agios Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Agios Pharmaceuticals Inc with three other companies in this sector in the United States: Clovis Oncology Inc (2018 sales of $95.39 million of which 100% was Anti Cancer Medicines), Amicus Therapeutics, Inc ($91.25 million of which 100% was Biopharmaceutical), and Melinta Therapeutics Inc ($96.43 million of which 100% was Pharmaceutical Preparations).

Sales Analysis. During the year ended December of 2018, sales at Agios Pharmaceuticals Inc were $94.39 million. This is an increase of 119.4% versus 2017, when the company's sales were $43.01 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Agios Pharmaceuticals Inc
  Stock Performance Chart for Agios Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 33.56
(Figures in U.S. Dollars)
1 Week -0.2%   13 Weeks 2.9%  
4 Weeks -22.0%   52 Weeks -51.4%  
Agios Pharmaceuticals Inc Key Data:
  Ticker: AGIO Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 94,387,000
(Year Ending Jan 2019).
Employees: 482
  Currency: U.S. Dollars Market Cap: 1,975,935,310
  Fiscal Yr Ends: December Shares Outstanding: 58,877,691
  Share Type: Common Closely Held Shares: 7,572,771
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.